(688506)“Sichuan Biokin Pharmaceutical Co., Ltd.”Announcement on Voluntary Disclosure of Obtaining Drug Clinical Trial Approval Notice for BL-M24D1 for Injection (ADC) in the Treatment of Relapsed or Refractory Hematologic Malignancies and Advanced Solid Tumors